captafol has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, L; Futakuchi, M; Hasegawa, R; Ito, N; Ogiso, T; Shirai, T; Yamamoto, A | 1 |
| Cabral, R; Hagiwara, A; Ito, N; Kawabe, M; Kurata, Y; Tamano, S; Yamamoto, A | 1 |
2 other study(ies) available for captafol and Experimental Hepatoma
| Article | Year |
|---|---|
Low susceptibility of the spontaneously hypertensive rat (SHR) to quinoline-induction of hepatic hemangioendothelial sarcomas.
Topics: Animals; Body Weight; Captan; Carcinogens; Cocarcinogenesis; Cyclohexenes; Disease Susceptibility; Fungicides, Industrial; Hemangioendothelioma; Hypertension; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1996 |
Carcinogenicity of captafol in F344/DuCrj rats.
Topics: Adenoma; Animals; Body Weight; Captan; Carcinoma, Renal Cell; Cyclohexenes; Diet; Dose-Response Relationship, Drug; Female; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Organ Size; Precancerous Conditions; Rats; Rats, Inbred F344; Sex Factors | 1990 |